Morgan Stanley’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Morgan Stanley’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-30,788	Closed	-$1.11M	–	7675
2020 Q4	$1.11M	Sell	30,788 -51,790	-63%	-$1.81M	﹤0.01%	4601
2020 Q3	$2.32M	Buy	82,578 +58,944	+249%	+$2.09M	﹤0.01%	3528
2020 Q2	$1.02M	Buy	23,634 +13,848	+142%	+$627K	﹤0.01%	4151
2020 Q1	$372K	Sell	9,786 -243	-2%	-$9.47K	﹤0.01%	4549
2019 Q4	$272K	Buy	+10,029	New	+$253K	﹤0.01%	5277

Morgan Stanley's VIE Position: Q1 2021 in Review

Morgan Stanley sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 30,788 shares — an estimated $1.11M sold.

Morgan Stanley first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $2.32M in Q3 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

Morgan Stanley reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Morgan Stanley sold 30,788 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $1.11M.
Morgan Stanley first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Morgan Stanley's Viela Bio, Inc. Common Stock position peaked at $2.32M in Q3 2020.
0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on Morgan Stanley's 13F filing for Q1 2021, filed 17 May 2021.